CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02168439
NCT02168439Phase 4Completed
CompareCT.gov

Double Blinded Randomized Controlled Trial of Intranasal Dexmedetomidine Versus Intranasal Midazolam as Anxiolysis Prior to Pediatric Laceration Repair in the Emergency Department

University of Pittsburgh·interventional·Posted Jun 20, 2014·Updated Nov 14, 2024

In Brief

A Phase 4 clinical trial evaluating Dexmedetomidine and Midazolam for Laceration and Anxiety. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The objective of this research study is to show superiority of intranasal dexmedetomidine to intranasal midazolam as anxiolysis prior to pediatric laceration repairs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLaceration, Anxiety
CountriesUnited States
CollaboratorsUniversity of Pittsburgh Clinical and Translational Science Institute (CTSI), National Center for Advancing Translational Sciences (NCATS)

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 20, 2014
Enrollment StartJun 1, 2014
Primary CompletionApr 1, 2015
Study CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 12.0 years ago

Interventions

Dexmedetomidinedrug

Midazolamdrug